Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) is expected to be the 3(rd) leading cause of death worldwide by 2020. Despite improvements in survival by using acute non-invasive ventilation (NIV) to treat patients with exacerbations of COPD complicated by acute hypercapnic respiratory failure (AHRF),...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578582/
https://www.ncbi.nlm.nih.gov/pubmed/33092618
http://dx.doi.org/10.1186/s13063-020-04672-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578582/
https://www.ncbi.nlm.nih.gov/pubmed/33092618
http://dx.doi.org/10.1186/s13063-020-04672-w

Ejemplares similares